Abstract
Enterovirus 71 (EV71) is the most important etiological agent of hand, foot, and mouth disease (HFMD) in young children, which is associated with severe neurological complications and has caused significant mortalities in recent HFMD outbreaks in Asia. However, there is no effective antiviral therapy against EV71. In this study, RNA interference (RNAi) was used as an antiviral strategy to inhibit EV71 replication. Three small interfering RNAs (siRNAs) targeting the 2Apro region of the EV71 genome were designed and synthesized. All the siRNAs were transfected individually into rhabdomyosarcoma (RD) cells, which were then infected with strain EV71-2006-52-9. The cytopathic effects (CPEs) in the infected RD cells, cell viability, viral titer, and viral RNA and protein expression were examined to evaluate the specific viral inhibition by the siRNAs. The results of cytopathogenicity and MTT tests indicated that the RD cells transfected with the three siRNAs showed slight CPEs and significantly high viability. The 50% tissue culture infective dose (TCID50) values demonstrated that the viral titer of the groups treated with three siRNAs were lower than those of the control groups. qRT-PCR and western blotting revealed that the levels ...Continue Reading
References
Mar 10, 2001·Genes & Development·P A Sharp
May 25, 2002·The Journal of General Virology·Rei-Lin KuoWu-Tse Liu
Jul 12, 2002·Nature·Gregory J Hannon
Nov 9, 2004·Biochemical and Biophysical Research Communications·Wen-Wen LuSzu-Hao Kung
Feb 22, 2005·Nature Medicine·Veit HornungGunther Hartmann
Aug 9, 2005·Virology·Adrian Chong Nyi SimChit Laa Poh
Apr 14, 2006·RNA·Angela ReynoldsAnastasia Khvorova
Jun 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wei-Hong WenAn-Gang Yang
Jun 19, 2008·Nucleic Acids Research·Rudy JulianoHyumin Kang
May 26, 2009·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Yoke-Fun ChanSazaly AbuBakar
Jun 6, 2009·Journal of Virological Methods·Zhiqiang WuQi Jin
Mar 17, 2010·Advanced Drug Delivery Reviews·Peixuan GuoYi Shu
May 13, 2010·Virology Journal·Yan ZhangWenbo Xu
Jul 1, 2011·Journal of Virology·Shin-Ru ShihMei-Ling Li
Sep 29, 2011·Virus Research·Ying LuanZhan-Feng Jin
Jan 4, 2012·Journal of Biomedical Science·Yi-Chen HsiehUNKNOWN Formosa Stroke Genetic Consortium (FSGC)
Sep 8, 2012·Clinical & Developmental Immunology·Shih-Min WangChing-Chuan Liu
Jan 24, 2013·Applied Biochemistry and Biotechnology·Puthucode Venkatakrishnan Ramachandran, Savarimuthu Ignacimuthu
Apr 26, 2013·Journal of Virology·Qixu CaiTianwei Lin
Jun 14, 2013·Evolutionary Bioinformatics Online·Dimitrios VlachakisSophia Kossida
Mar 31, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Yi-Fang TuChao-Ching Huang
Jun 4, 2015·Virology Journal·Ying WangRalf Altmeyer
Jul 1, 2015·Scientific Reports·Xiaobo FengZhirong Yao
Citations
Sep 5, 2019·Journal of Biomedical Science·Jing-Yi LinShin-Ru Shih
May 5, 2017·Frontiers in Cellular and Infection Microbiology·Xiaoxia YangHongbin Song
Oct 24, 2018·Frontiers in Microbiology·Yuefei JinGuangcai Duan
Nov 15, 2018·International Journal of Molecular Sciences·Wannita KlinngamSarah F Hamm-Alvarez
Aug 13, 2021·Expert Opinion on Drug Discovery·Chih-Yeu Fang, Chia-Chyi Liu